Detalhe da pesquisa
1.
Population-based impact of COVID-19 on incidence, treatment, and survival of patients with pancreatic cancer.
HPB (Oxford)
; 25(10): 1195-1202, 2023 10.
Artigo
Inglês
| MEDLINE | ID: mdl-37236831
2.
Real-world evidence of adjuvant gemcitabine plus capecitabine vs gemcitabine monotherapy for pancreatic ductal adenocarcinoma.
Int J Cancer
; 150(10): 1654-1663, 2022 05 15.
Artigo
Inglês
| MEDLINE | ID: mdl-34935139
3.
Treatment and overall survival of four types of non-metastatic periampullary cancer: nationwide population-based cohort study.
HPB (Oxford)
; 24(9): 1433-1442, 2022 09.
Artigo
Inglês
| MEDLINE | ID: mdl-35135724
4.
Adjuvant and first-line palliative chemotherapy regimens in patients diagnosed with periampullary cancer: a short report from a nationwide registry.
Acta Oncol
; 61(5): 591-596, 2022 05.
Artigo
Inglês
| MEDLINE | ID: mdl-35382678
5.
Trastuzumab plus pertuzumab for HER2-amplified advanced colorectal cancer: Results from the drug rediscovery protocol (DRUP).
Eur J Cancer
; 202: 113988, 2024 May.
Artigo
Inglês
| MEDLINE | ID: mdl-38471288
6.
A population-based study on incidence, treatment, and survival in ampullary cancer in the Netherlands.
Eur J Surg Oncol
; 47(7): 1742-1749, 2021 07.
Artigo
Inglês
| MEDLINE | ID: mdl-33712346
7.
Liquid chromatography-tandem mass spectrometric assay for the PARP-1 inhibitor olaparib in combination with the nitrogen mustard melphalan in human plasma.
J Chromatogr B Analyt Technol Biomed Life Sci
; 879(21): 1851-6, 2011 Jul 01.
Artigo
Inglês
| MEDLINE | ID: mdl-21622034